GlassScriptPhysician profile
Jodi A Conley
NPI 1891860599
$6,240.63
in general payments reported to CMS, 2019-2025
40 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,528 · 2022: $1,215 · 2023: $1,272 · 2024: $1,196 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,497.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,113.02 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Abbvie INC. | $860.32 | 2021-2025 | |
| Lilly USA, LLC | $665.22 | 2021-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $648.23 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $621.97 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Grifols USA, LLC | $245.87 | 2022-2025 | Prolastin-C Liquid, Xembify |
| Biohaven Pharmaceuticals, INC. | $196.39 | 2021 | |
| Pfizer INC. | $195.68 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $186.87 | 2022 | |
| Merck Sharp & Dohme LLC | $170.02 | 2021-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $152.97 | 2024-2025 | Caplyta |
| Dexcom, INC. | $146.88 | 2021-2025 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $96.82 | 2021-2022 | |
| Amgen INC. | $93.55 | 2021-2024 | Prolia, Evenity |
| Novartis Pharmaceuticals Corporation | $81.25 | 2021-2023 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.